Search Result
CORT | Corcept Therapeutics Inc Corcept Therapeutics Incorporated
You can also get more CORT info from:
Revenue Track
Quarterly Annual
Stock price graph
1M 3M 1y 5Y All
Rank
Default▼ Market Value Year Founded IPO A-Z CRG Score
CORT | Corcept Therapeutics Inc
Manufacturing | Pharmaceutical Preparation Manufacturing
Market Value: $2.75 Billion
Shares: 107,105,078
52-Week Range: 16-30
PS Ratio Estimate: 5.3 (based on most recent quarter revenue x 4)
CRG Score: 10
IPO: 2004-04-14 Year Founded: 1998-05-13
Core Business: Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
QTsky is a question & task based crowdsourcing research platform - you can post any research need - whether it's a simple question or a complex task - and find the right industry expert or software engineer to help you obtain the right answer or solution. And you only pay on a per-question or per-task basis after your QT is completed

QTsky.com and all of its information providers will not be liable for any errors,omissions,delays or interruptions in all the information and data on the QTsky.com website or for any damages relating to your use of the information provided herein. All data,research findings,opinions and information herein, whether provided by QTsky.com or by its users,should not be treated as professional investment advice.

   All Rights Reserved ® SVI | To Top